Gene · 6423
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas. | Clin Epigenetics | 2023 | 37794510 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth. | Sci Rep | 2023 | 37783752 | PubTator, text mining | PubMed |
| The performance of FIT-based and other risk prediction models for colorectal neoplasia in symptomatic patients: a systematic review. | EClinicalMedicine | 2023 | 37781155 | PubTator, text mining | PubMed |
| Peripheral mechanisms of peripheral neuropathic pain. | Front Mol Neurosci | 2023 | 37781093 | PubTator, text mining | PubMed |
| Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression. | Cancer Discov | 2023 | 37768068 | PubTator, text mining | PubMed |
| Skin Cancer Microenvironment: What We Can Learn from Skin Aging? | Int J Mol Sci | 2023 | 37762344 | PubTator, text mining | PubMed |
| Cytocompatibility and Osteoinductive Properties of Collagen-Fibronectin Hydrogel Impregnated with siRNA Targeting Glycogen Synthase Kinase 3β: In Vitro Study. | Biomedicines | 2023 | 37760805 | PubTator, text mining | PubMed |
| Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors. | Stem Cell Rev Rep | 2023 | 37755647 | PubTator, text mining | PubMed |
| Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma. | Cancer Cell Int | 2023 | 37749554 | PubTator, text mining | PubMed |
| Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers. | Sci Rep | 2023 | 37730904 | PubTator, text mining | PubMed |
| Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application. | Transl Neurodegener | 2023 | 37726850 | PubTator, text mining | PubMed |
| Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties. | Stem Cell Res Ther | 2023 | 37726837 | PubTator, text mining | PubMed |
| Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer. | Front Pharmacol | 2023 | 37719843 | PubTator, text mining | PubMed |
| Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Front Genet | 2023 | 37719698 | PubTator, text mining | PubMed |
| Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer. | Sci Rep | 2023 | 37717096 | PubTator, text mining | PubMed |
| A possible genetic association between obesity and colon cancer in females. | Front Endocrinol (Lausanne) | 2023 | 37711894 | PubTator, text mining | PubMed |
| Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV. | Front Immunol | 2023 | 37711619 | PubTator, text mining | PubMed |
| MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach. | Bioinform Biol Insights | 2023 | 37701630 | PubTator, text mining | PubMed |
| Transcriptional expression, prognostic value and immune infiltration of SFRP family in colorectal cancer: a study based on comprehensive bioinformatics and in vitro analyses. | Transl Cancer Res | 2023 | 37701102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6423/papers?page=13